Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001415889-24-002320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-01-31 | PCVX | Lukatch Heath | Dir | S - Sale+OE | $71.50 | -5,000 | 5,625 | -47% | -$357.5K |
| D | 2024-02-02 | 2024-01-31 | PCVX | Lukatch Heath | Dir | M - OptEx | $16.00 | +5,000 | 10.6K | +89% | +$80.0K |
| D | 2024-02-02 | 2024-01-31 | PCVX | Lukatch Heath | Dir | M - OptEx | $0.00 | -5,000 | 6,000 | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-31 | S | D | 5,000 | $71.50 | 5,625 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-31 | M | A | 5,000 | $16.00 | 10,625 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-01-31 | M | D | 5,000 | $0.00 | 6,000 | D | $16.00 · — to 2030-06-10 | 5,000 Common Stock | (F2) Fully vested and exercisable. |